Alternate dosing regimens of brentuximab vedotin for CD30+cutaneous T-cell lymphoma: reply from the authors

作者:Stranzenbach R.*; Dippel E.; Schlaak M.; Stadler R.*
来源:British Journal of Dermatology, 2018, 178(1): 303-303.
DOI:10.1111/bjd.15972